↓ Skip to main content

A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma

Overview of attention for article published in Frontiers in oncology, July 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma
Published in
Frontiers in oncology, July 2024
DOI 10.3389/fonc.2024.1407001
Pubmed ID
Authors

Kanwal Asghar, Maryam Zafar, Eva Holland, Ali Bin Abduljabbar, Sara A. Albagoush, Noureen Asghar, Akshat Sood, Jalal M. Dufani, Joseph Thirumalaredy, Bradley DeVrieze, Abubakar Tauseef, Muhammad Husnain

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 1 50%
Student > Master 1 50%
Readers by discipline Count As %
Unspecified 1 50%
Medicine and Dentistry 1 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2024.
All research outputs
#17,547,987
of 26,515,106 outputs
Outputs from Frontiers in oncology
#7,025
of 23,233 outputs
Outputs of similar age
#114,775
of 247,523 outputs
Outputs of similar age from Frontiers in oncology
#36
of 314 outputs
Altmetric has tracked 26,515,106 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,233 research outputs from this source. They receive a mean Attention Score of 3.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,523 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 314 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.